Klinika Onkologii, Wojskowy Instytut Medyczny
Warsaw 04-141
0 studies enrolling now · 2 studies all time
What they study most
Kidney Neoplasms
Studies at this site
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
— Completed
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer
— Completed